Previous works by our and other groups have associated PRMT5 with the regulation of DDR genes in blood and prostate cancers (14, 16), although the precise mechanisms remain unclear and therapeutic opportunities continue to be explored. The gene discussed is PRMT5; the disease is prostate cancer.